An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

@article{Dawson2006AnIA,
  title={An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition},
  author={G. R. Dawson and K. Maubach and N. Collinson and M. Cobain and B. Everitt and A. Macleod and H. Choudhury and L. McDonald and G. Pillai and W. Rycroft and A. Smith and F. Sternfeld and F. Tattersall and K. Wafford and D. Reynolds and G. Seabrook and J. Atack},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2006},
  volume={316},
  pages={1335 - 1345}
}
  • G. R. Dawson, K. Maubach, +14 authors J. Atack
  • Published 2006
  • Chemistry, Medicine
  • Journal of Pharmacology and Experimental Therapeutics
  • α5IA is a compound that binds with equivalent subnanomolar affinity to the benzodiazepine (BZ) site of GABAA receptors containing an α1, α2, α3, or α5 subunit but has inverse agonist efficacy selective for the α5 subtype. As a consequence, the in vitro and in vivo effects of this compound are mediated primarily via GABAA receptors containing an α5 subunit. In a mouse hippocampal slice model, α5IA significantly enhanced the θ burst-induced long-term potentiation of the excitatory postsynaptic… CONTINUE READING
    208 Citations
    RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors
    • 142
    • Highly Influenced
    Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA.
    • J. Atack
    • Medicine
    • Pharmacology & therapeutics
    • 2010
    • 85
    L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors
    • 155
    • PDF
    Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice
    • 144
    • Highly Influenced
    Selective Modulators of α5-Containing GABAA Receptors and their Therapeutic Significance.
    • 18
    • PDF
    Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist
    • 43
    MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans
    • 48
    • PDF

    References

    SHOWING 1-10 OF 64 REFERENCES
    Trace fear conditioning involves hippocampal α5 GABAA receptors
    • 463
    • PDF
    Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
    • 1,029
    • Highly Influential
    Modulation of Long-term Potentiation in CA1 Region of Mouse Hippocampal Brain Slices by GABAA Receptor Benzodiazepine Site Ligands
    • 76
    Anxiogenic properties of an inverse agonist selective for α3 subunit‐containing GABAA receptors
    • 110
    Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics.
    • 508
    Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
    • 862